Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… Symposium: Innovative Payment Models in Alzheimer’s Disease Share on: Friday, November 11, 2022 Event Website … (JIM) Symposium: Innovative Payment Models in Alzheimer’s Disease. Determining the value of disease-modifying therapies … 09:45-10:15 The JIM symposium will provide a critical assessment of the applicability of innovative payment models …
… that evaluates health technologies in the US. ICER’s value assessment framework is similar to frameworks used by major …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …
… post-market pregnancy requirements and safety in rare disease and gene therapy. Here are the details. #314: Registries Aren’t Always … studies. #362: Assessing Safety in Rare Disease and Gene Therapy Wednesday, June 28 • 4:00pm - 5:00pm Chair: Alicia …
… Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data …
… Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data …
… treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle … The annual economic burden of adverse events and other disease-related medical costs of CLL alone in the United … with chronic lymphocytic leukemia receiving systemic therapy: real-world evidence from the Medicare population . …
… to successfully implement PRO measurement within the drug development program to generate data to support … to negotiate regulatory, reimbursement, and market access drug development hurdles. Judging PRO instrument quality and …
… and promote engagement and collaboration with patients, industry, academia, and consumers. Visit the …
… sources or surveys , can help you understand: Clinical disease characteristics Disease progression, survival, and treatment response … Selected physicians then abstract data from their own patients’ charts based upon patient selection criteria …